StockWatch
·
Pharmaceuticals
Corporate Action7 Nov 2026, 12:31 pm

Sanjivani Paranteral: BSE Grants In-Principle Approval for Warrant Issue

AI Summary

Sanjivani Paranteral Limited has received an in-principle approval from BSE Limited for the proposed issue of 5,00,000 warrants convertible into equity shares. These warrants will be issued to the promoter on a preferential basis at a price not less than ₹147.39 per warrant. The approval is subject to statutory and regulatory clearances. This in-principle approval does not confirm listing of the securities; the company must complete post-issue formalities and apply for listing upon allotment. BSE has advised the company to strengthen internal controls and obtain undertakings from allottees to prevent non-compliance with SEBI regulations.

Key Highlights

  • BSE grants in-principle approval for preferential issue of warrants.
  • 5,00,000 warrants to be issued, convertible into equity shares.
  • Issue price not less than ₹147.39 per warrant to promoter.
  • Approval is conditional on statutory, regulatory compliance.
  • Company advised to strengthen internal controls and obtain undertakings.